{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T05:29:53Z","timestamp":1740806993988,"version":"3.38.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00063-024-01216-x","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T08:29:42Z","timestamp":1732868982000},"page":"129-134","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Innerklinische Versorgung von intrazerebralen Blutungen","In-hospital management of intracerebral hemorrhage"],"prefix":"10.1007","volume":"120","author":[{"given":"Jochen","family":"Sembill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,29]]},"reference":[{"key":"1216_CR1","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S1474-4422(18)30253-9","volume":"17","author":"R Al-Shahi Salman","year":"2018","unstructured":"Al-Shahi Salman\u00a0R, Frantzias\u00a0J, Lee\u00a0RJ et\u00a0al (2018) Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a\u00a0systematic review and meta-analysis of individual patient data. Lancet Neurol 17:885\u2013894","journal-title":"Lancet Neurol"},{"key":"1216_CR2","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1016\/S0140-6736(24)00702-5","volume":"403","author":"J Beck","year":"2024","unstructured":"Beck\u00a0J, Fung\u00a0C, Strbian\u00a0D et\u00a0al (2024) Decompressive craniectomy plus best medical treatment versus best medical treatment alone for spontaneous severe deep supratentorial intracerebral haemorrhage: a\u00a0randomised controlled clinical trial. Lancet 403:2395\u20132404","journal-title":"Lancet"},{"key":"1216_CR3","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1177\/2396987319849763","volume":"4","author":"H Christensen","year":"2019","unstructured":"Christensen\u00a0H, Cordonnier\u00a0C, Korv\u00a0J et\u00a0al (2019) European Stroke Organisation Guideline on Reversal of Oral Anticoagulants in Acute Intracerebral Haemorrhage. Eur Stroke\u00a0J 4:294\u2013306","journal-title":"Eur Stroke J"},{"key":"1216_CR4","first-page":"10","volume":"2023","author":"SJ Connolly","year":"2023","unstructured":"Connolly\u00a0SJ (2023) Randomized trial of andexanet alfa versus usual care in patients with acute intracranial hemorrhage while on an oral factor\u00a0Xa inhibitor: ANNEXA\u2011I. 15th World Stroke Congr 2023:10\u201312","journal-title":"15th World Stroke Congr"},{"key":"1216_CR5","first-page":"CD005951","volume":"10","author":"H Eilertsen","year":"2023","unstructured":"Eilertsen\u00a0H, Menon\u00a0CS, Law\u00a0ZK et\u00a0al (2023) Haemostatic therapies for stroke due to acute, spontaneous intracerebral haemorrhage. Cochrane Database Syst Rev 10:CD5951","journal-title":"Cochrane Database Syst Rev"},{"key":"1216_CR6","doi-asserted-by":"publisher","first-page":"e282","DOI":"10.1161\/STR.0000000000000407","volume":"53","author":"SM Greenberg","year":"2022","unstructured":"Greenberg\u00a0SM, Ziai\u00a0WC, Cordonnier\u00a0C et\u00a0al (2022) 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A\u00a0Guideline From the American Heart Association\/American Stroke Association. Stroke 53:e282\u2013e361","journal-title":"Stroke"},{"key":"1216_CR7","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0140-6736(16)32410-2","volume":"389","author":"DF Hanley","year":"2017","unstructured":"Hanley\u00a0DF, Lane\u00a0K, Mcbee\u00a0N et\u00a0al (2017) Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial. Lancet 389:603\u2013611","journal-title":"Lancet"},{"key":"1216_CR8","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S0140-6736(19)30195-3","volume":"393","author":"DF Hanley","year":"2019","unstructured":"Hanley\u00a0DF, Thompson\u00a0RE, Rosenblum\u00a0M et\u00a0al (2019) Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a\u00a0randomised, controlled, open-label, blinded endpoint phase\u00a03\u00a0trial. Lancet 393:1021\u20131032","journal-title":"Lancet"},{"key":"1216_CR9","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1001\/jama.2019.13014","volume":"322","author":"JB Kuramatsu","year":"2019","unstructured":"Kuramatsu\u00a0JB, Biffi\u00a0A, Gerner\u00a0ST et\u00a0al (2019) Association of Surgical Hematoma Evacuation vs Conservative Treatment With Functional Outcome in Patients With Cerebellar Intracerebral Hemorrhage. JAMA 322:1392\u20131403","journal-title":"JAMA"},{"key":"1216_CR10","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1001\/jama.2015.0846","volume":"313","author":"JB Kuramatsu","year":"2015","unstructured":"Kuramatsu\u00a0JB, Gerner\u00a0ST, Schellinger\u00a0PD et\u00a0al (2015) Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. JAMA 313:824\u2013836","journal-title":"JAMA"},{"key":"1216_CR11","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1161\/STROKEAHA.121.038455","volume":"53","author":"JB Kuramatsu","year":"2022","unstructured":"Kuramatsu\u00a0JB, Gerner\u00a0ST, Ziai\u00a0W et\u00a0al (2022) Association of Intraventricular Fibrinolysis With Clinical Outcomes in Intracerebral Hemorrhage: An Individual Participant Data Meta-Analysis. Stroke 53:2876\u20132886","journal-title":"Stroke"},{"key":"1216_CR12","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1056\/NEJMoa2314741","volume":"390","author":"G Li","year":"2024","unstructured":"Li\u00a0G, Lin\u00a0Y, Yang\u00a0J et\u00a0al (2024) Intensive Ambulance-Delivered Blood-Pressure Reduction in Hyperacute Stroke. N\u00a0Engl J Med 390:1862\u20131872","journal-title":"N Engl J Med"},{"key":"1216_CR13","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/ana.25793","volume":"88","author":"Q Li","year":"2020","unstructured":"Li\u00a0Q, Warren\u00a0AD, Qureshi\u00a0AI et\u00a0al (2020) Ultra-Early Blood Pressure Reduction Attenuates Hematoma Growth and Improves Outcome in Intracerebral Hemorrhage. Ann Neurol 88:388\u2013395","journal-title":"Ann Neurol"},{"key":"1216_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(23)00806-1","volume":"402","author":"L Ma","year":"2023","unstructured":"Ma\u00a0L, Hu\u00a0X, Song\u00a0L et\u00a0al (2023) The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial. Lancet 402:27\u201340","journal-title":"Lancet"},{"key":"1216_CR15","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1056\/NEJMoa0707534","volume":"358","author":"SA Mayer","year":"2008","unstructured":"Mayer\u00a0SA, Brun\u00a0NC, Begtrup\u00a0K et\u00a0al (2008) Efficacy and safety of recombinant activated factor\u00a0VII for acute intracerebral hemorrhage. N\u00a0Engl J Med 358:2127\u20132137","journal-title":"N Engl J Med"},{"key":"1216_CR16","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(13)60986-1","volume":"382","author":"AD Mendelow","year":"2013","unstructured":"Mendelow\u00a0AD, Gregson\u00a0BA, Rowan\u00a0EN et\u00a0al (2013) Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a\u00a0randomised trial. Lancet 382:397\u2013408","journal-title":"Lancet"},{"key":"1216_CR17","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/S1474-4422(20)30369-0","volume":"19","author":"A Meretoja","year":"2020","unstructured":"Meretoja\u00a0A, Yassi\u00a0N, Wu\u00a0TY et\u00a0al (2020) Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a\u00a0multicentre, randomised, placebo-controlled, phase\u00a02\u00a0trial. Lancet Neurol 19:980\u2013987","journal-title":"Lancet Neurol"},{"key":"1216_CR18","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S1474-4422(19)30196-6","volume":"18","author":"TJ Moullaali","year":"2019","unstructured":"Moullaali\u00a0TJ, Wang\u00a0X, Martin\u00a0RH et\u00a0al (2019) Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a\u00a0preplanned pooled analysis of individual participant data. Lancet Neurol 18:857\u2013864","journal-title":"Lancet Neurol"},{"key":"1216_CR19","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S1474-4422(22)00235-6","volume":"21","author":"L Peter-Derex","year":"2022","unstructured":"Peter-Derex\u00a0L, Philippeau\u00a0F, Garnier\u00a0P et\u00a0al (2022) Safety and efficacy of prophylactic levetiracetam for prevention of epileptic seizures in the acute phase of intracerebral haemorrhage (PEACH): a\u00a0randomised, double-blind, placebo-controlled, phase\u00a03\u00a0trial. Lancet Neurol 21:781\u2013791","journal-title":"Lancet Neurol"},{"key":"1216_CR20","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1056\/NEJMoa1707278","volume":"377","author":"CV Pollack Jr.","year":"2017","unstructured":"Pollack\u00a0CV Jr., Reilly\u00a0PA, Van Ryn\u00a0J et\u00a0al (2017) Idarucizumab for Dabigatran reversal\u2014full cohort analysis. N\u00a0Engl J Med 377:431\u2013441","journal-title":"N Engl J Med"},{"key":"1216_CR21","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1056\/NEJMoa2308440","volume":"390","author":"G Pradilla","year":"2024","unstructured":"Pradilla\u00a0G, Ratcliff\u00a0JJ, Hall\u00a0AJ et\u00a0al (2024) Trial of Early Minimally Invasive Removal of Intracerebral Hemorrhage. N\u00a0Engl J Med 390:1277\u20131289","journal-title":"N Engl J Med"},{"key":"1216_CR22","doi-asserted-by":"publisher","first-page":"XLVIII","DOI":"10.1177\/23969873211012133","volume":"6","author":"EC Sandset","year":"2021","unstructured":"Sandset\u00a0EC, Anderson\u00a0CS, Bath\u00a0PM et\u00a0al (2021) European Stroke Organisation (ESO) guidelines on blood pressure management in acute ischaemic stroke and intracerebral haemorrhage. Eur Stroke\u00a0J 6:XLVIII\u2013LXXXIX","journal-title":"Eur Stroke J"},{"key":"1216_CR23","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/ana.25969","volume":"89","author":"JA Sembill","year":"2021","unstructured":"Sembill\u00a0JA, Castello\u00a0JP, Sprugel\u00a0MI et\u00a0al (2021) Multicenter Validation of the max-ICH Score in Intracerebral Hemorrhage. Ann Neurol 89:474\u2013484","journal-title":"Ann Neurol"},{"key":"1216_CR24","first-page":"423","volume":"89","author":"JA Sembill","year":"2017","unstructured":"Sembill\u00a0JA, Gerner\u00a0ST, Volbers\u00a0B et\u00a0al (2017) Severity assessment in maximally treated ICH patients: The max-ICH score. Baillieres Clin Neurol 89:423\u2013431","journal-title":"Baillieres Clin Neurol"},{"key":"1216_CR25","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/acn3.51001","volume":"7","author":"JA Sembill","year":"2020","unstructured":"Sembill\u00a0JA, Kuramatsu\u00a0JB, Gerner\u00a0ST et\u00a0al (2020) Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage. Ann Clin Transl Neurol 7:363\u2013374","journal-title":"Ann Clin Transl Neurol"},{"key":"1216_CR26","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/jamaneurol.2022.1991","volume":"79","author":"VA Shah","year":"2022","unstructured":"Shah\u00a0VA, Thompson\u00a0RE, Yenokyan\u00a0G et\u00a0al (2022) One-Year Outcome Trajectories and Factors Associated with Functional Recovery Among Survivors of Intracerebral and Intraventricular Hemorrhage With Initial Severe Disability. JAMA Neurol 79:856\u2013868","journal-title":"JAMA Neurol"},{"key":"1216_CR27","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1016\/S0140-6736(18)31033-X","volume":"391","author":"N Sprigg","year":"2018","unstructured":"Sprigg\u00a0N, Flaherty\u00a0K, Appleton\u00a0JP et\u00a0al (2018) Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase\u00a03 superiority trial. Lancet 391:2107\u20132115","journal-title":"Lancet"},{"key":"1216_CR28","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1136\/jnnp-2018-319786","volume":"90","author":"MI Sprugel","year":"2019","unstructured":"Sprugel\u00a0MI, Sembill\u00a0JA, Kuramatsu\u00a0JB et\u00a0al (2019) Heparin for prophylaxis of venous thromboembolism in intracerebral haemorrhage. J\u00a0Neurol Neurosurg Psychiatry 90:783\u2013791","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1216_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/ana.24834","volume":"81","author":"D Staykov","year":"2017","unstructured":"Staykov\u00a0D, Kuramatsu\u00a0JB, Bardutzky\u00a0J et\u00a0al (2017) Efficacy and safety of combined intraventricular fibrinolysis with lumbar drainage for prevention of permanent shunt dependency after intracerebral hemorrhage with severe ventricular involvement: A\u00a0randomized trial and individual patient data meta-analysis. Ann Neurol 81:93\u2013103","journal-title":"Ann Neurol"},{"key":"1216_CR30","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/S1474-4422(16)00110-1","volume":"15","author":"T Steiner","year":"2016","unstructured":"Steiner\u00a0T, Poli\u00a0S, Griebe\u00a0M et\u00a0al (2016) Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin\u00a0K antagonists (INCH): a\u00a0randomised trial. Lancet Neurol 15:566\u2013573","journal-title":"Lancet Neurol"},{"key":"1216_CR31","doi-asserted-by":"publisher","first-page":"100842","DOI":"10.1016\/j.lanepe.2024.100842","volume":"38","author":"HA Wafa","year":"2024","unstructured":"Wafa\u00a0HA, Marshall\u00a0I, Wolfe\u00a0CDA et\u00a0al (2024) Burden of intracerebral haemorrhage in Europe: forecasting incidence and mortality between 2019 and 2050. Lancet Reg Health Eur 38:100842","journal-title":"Lancet Reg Health Eur"},{"key":"1216_CR32","doi-asserted-by":"publisher","first-page":"e0234957","DOI":"10.1371\/journal.pone.0234957","volume":"15","author":"V Yogendrakumar","year":"2020","unstructured":"Yogendrakumar\u00a0V, Lun\u00a0R, Khan\u00a0F et\u00a0al (2020) Venous thromboembolism prevention in intracerebral hemorrhage: A\u00a0systematic review and network meta-analysis. PLoS ONE 15:e234957","journal-title":"PLoS ONE"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-024-01216-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00063-024-01216-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-024-01216-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T11:45:30Z","timestamp":1740743130000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00063-024-01216-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1216"],"URL":"https:\/\/doi.org\/10.1007\/s00063-024-01216-x","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"type":"print","value":"2193-6218"},{"type":"electronic","value":"2193-6226"}],"subject":[],"published":{"date-parts":[[2024,11,29]]},"assertion":[{"value":"11 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.\u00a0Sembill und S.\u00a0Schwab geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}